Five experiments that induced postnatal iron overload in mice are described. In Experiment I, exposure of NMRI mice to different doses (iron succinate: 0.0, 3.7 or 37.0 mg Fe 2+ /kg b. w., p.o.) on postnatal days (PD) 10 -PD12 indicated marked disruptions of spontaneous motor behaviour and habituation in the 37.0 mg Fe 2+ /kg dose group, and to a lesser extent the 3.7 mg Fe 2+ /kg dose group. Analysis of brain iron content indicated significantly more total iron (μg/g) in the basal ganglia, but not frontal cortex of the higher, 37 mg/kg, dose group. In Experiment II, newborn NMRI mice were administered Fe 2+ (7.5 mg/kg, b.w.) at either PD 3-5, PD 10-12 or PD 19-21, or vehicle (saline). Marked deficits in spontaneous motor behaviour and habituation were obtained in the mice administered iron during PD 10-12, and to a much lesser extent at PD 3-5. Analysis of total brain iron content indicated significantly more iron (mg/g) in the basal ganglia, but not frontal cortex of mice from PD 3-5 and PD 10-12 Fe 2+ treatment groups. In Experiment III, the interactive effects of postnatal iron overload and administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to adult C57 BL/6 mice were examined by postnatal administration of iron (Fe 2+ ) 7.5 mg/kg, b. wt., p.o. or vehicle (saline) at PD 10-12 followed, at 3-months of age, by administration of either MPTP (2 x 20 or 2 x 40 mg/kg, s.c.) or saline. Postnatal Fe 2+ (7.5 mg/kg) caused drastic disruptions of spontaneous motor activity and habituation at behavioural testing (4-months age), and adult MPTP treatment potentiated these disruptions. Neurochemical deficits in dopamine (DA) and its metabolites (dihydroxyphenylacetic acid, DOPAC; homovanillic acid, HVA) induced by MPTP treatment were exacerbated by prior postnatal administration of Fe 2+ . The analysis of total iron content (mg/g) in brain regions indicated notably elevated levels in the basal ganglia, but not in the frontal cortex of mice administered Fe 2+ at PD 10-12. MPTP-treated mice displayed severe depletions of DA, DOPAC and HVA in both the striatal and frontal cortical regions, i.e. Veh-MPTP40 as well as Fe-MPTP20 and Fe-MPTP40 groups, compared to the saline-treated (Vehicle) mice at 4-months of age, with lesser depletions by the Veh-MPTP20 group. In Experiment IV it was indicated that postnatal iron induced marked deficits (hypoactivity), initially, in all three parameters of motor activity at the 5.0 and 7.5 mg/kg doses, and to a lesser extent at the 2.5 mg/kg dose. Later combination with MPTP (2 x 40 mg/kg) potentiated severely these deficits. During the final period of testing a marked hyperactivity was obtained for the two higher dose groups; this effect was abolished in mice administered MPTP. In Experiment V, postnatal iron-induced deficits were alleviated in a dose-related manner by co-administration of the uncompetitive glutamate receptor antagonist, dizolcipine (MK-801), with a subthreshold dose of L-Dopa. Iron-overload during the immediate postnatal period seems detrimental for several...